Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04450914 · ClinicalTrials.gov registry record · NA
Implementing Shared Decision Making (SDM) For Individualized CV Prevention (SDM4IP)
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 112,127
- Enrollment target
NCT04450914: Completed NA study, sponsored by Mayo Clinic.
NCT04450914 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 112,127 participants, above the 1,402-participant average among 58,714 other NA trials with a reported enrollment target (7898% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04450914, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 112,127 participants
- Enrollment target
Study Summary
Cardiovascular (CV) disease is the #1 cause of premature mortality and substantial morbidity in the U.S. Despite clinical guidelines, most clinical interventions are implemented in people at relatively lower CV risk, and few among people at the highest risk. Shared decision making (SDM) can mitigate the risk-treatment paradox by reducing risk blindness and lack of fit of the preventive regimen, but the adoption of SDM in routine clinical care is incomplete. This study addresses SDM adoption of a CV prevention SDM tool in three health systems.
Primary Outcome
Percentage of clinicians who used CV Prevention Choice, among all eligible clinicians in participating settings. Clinicians were eligible if they had at least one encounter during the period evaluated. Utilization was recorded in the electronic health record. Higher percentages indicate greater intervention reach.
Interventions
- BEHAVIORAL CV Prevention Choice Tool
- BEHAVIORAL Implementation Facilitation Strategies
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112,127 participants |
| Start Date | 2021-05-10 |
| Est. Completion | 2025-04-29 |
| Phase | NA |
What the finished NCT04450914 record still lists
NCT04450914 is an interventional study that assigns participants to a tested intervention. Its 112,127 participants enrollment target places it among the larger protocols in the corpus, above the 1,402-participant average among 58,714 other NA trials with a reported enrollment target (7898% higher).
The record links to 0 conditions, and to 2 interventions - of which CV Prevention Choice Tool is the first listed.
NCT04450914 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04450914 about?
NCT04450914 is a clinical study titled "Implementing Shared Decision Making (SDM) For Individualized CV Prevention (SDM4IP)". Cardiovascular (CV) disease is the #1 cause of premature mortality and substantial morbidity in the U.S. Despite clinical guidelines, most clinical interventions are implemented in people at relatively lower CV risk, and few among people at the highest risk. Shared decision making (SDM) can mitigate...
What is the current status of trial NCT04450914?
This trial is currently completed. It is a NA study. The enrollment target is 112,127 participants. The study started on 2021-05-10. Estimated completion is 2025-04-29.
What interventions are being tested in trial NCT04450914?
The interventions under investigation include: CV Prevention Choice Tool (BEHAVIORAL), Implementation Facilitation Strategies (BEHAVIORAL).
Who is sponsoring clinical trial NCT04450914?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04450914's enrollment target sits among peer trials
112,127 2nd of 2000 the highest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05804188 · 105,000 participants
CRICKET: Critical Events in Anaesthetised Kids Undergoing Tracheal Intubation
- NCT06251323 · 119,680 participants · NA
Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)
- NCT03897374 · 120,000 participants
Strategic Targeting for Optimal Prevention of Cancer
- NCT06608758 · 120,000 participants
End Diagnostic Overshadowing:Addressing Ableism in Diagnoses
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI